TFOS DEWS II Epidemiology Report Fiona Stapleton, MCOptom, PhD, Monica Alves, MD, PhD, Vatinee Y. Bunya, MD, Isabelle Jalbert, OD, PhD, Kaevalin Lekhanont, MD, Florence Malet, MD, Kyung-Sun Na, MD, PhD, Debra Schaumberg, ScD, OD, Miki Uchino, MD, PhD, Jelle Vehof, MD, PhD, Eloy Viso, MD, PhD, Susan Vitale, PhD, MHS, Lyndon Jones, FCOptom, PhD  The Ocular Surface  Volume 15, Issue 3, Pages 334-365 (July 2017) DOI: 10.1016/j.jtos.2017.05.003 Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 1 Literature search outcome for DED prevalence studies. The Ocular Surface 2017 15, 334-365DOI: (10.1016/j.jtos.2017.05.003) Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 2 Prevalence map according to the WHS diagnostic criteria (upper panel) and self-report of clinically diagnosed dry eye (lower panel). The Ocular Surface 2017 15, 334-365DOI: (10.1016/j.jtos.2017.05.003) Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 3 Prevalence map of symptomatic disease (upper panel) and expanded view of studies carried out in South East Asia (lower panel). The Ocular Surface 2017 15, 334-365DOI: (10.1016/j.jtos.2017.05.003) Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 4 Prevalence map of MGD (upper panel) and tear film instability (TBUT <8-10 sec) disease (lower panel). The Ocular Surface 2017 15, 334-365DOI: (10.1016/j.jtos.2017.05.003) Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 5 Prevalence of symptomatic disease (upper), WHS criteria (central) and clinically diagnosed dry eye (lower panel) by age. The number of studies reporting prevalence is shown above the x-axis. The Ocular Surface 2017 15, 334-365DOI: (10.1016/j.jtos.2017.05.003) Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 6 The prevalence of DED signs by age. The Ocular Surface 2017 15, 334-365DOI: (10.1016/j.jtos.2017.05.003) Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 7 Prevalence of symptomatic disease (upper), clinically diagnosed dry eye (central) and WHS criteria (lower panel) by age and sex. The number of studies reporting prevalence is shown above the x-axis. The Ocular Surface 2017 15, 334-365DOI: (10.1016/j.jtos.2017.05.003) Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 8 The prevalence of DED signs (TBUT, top left; Schirmer, top right; fluorescein staining, lower left; and MGD, lower right) by age and sex. The Ocular Surface 2017 15, 334-365DOI: (10.1016/j.jtos.2017.05.003) Copyright © 2017 Elsevier Inc. Terms and Conditions